Abstract:Over the past several years, numerous studies investigated the anti-inflammatory effects of statin on patients with RA. However, the findings of the individual studies were often inconsistent or conflicting.The Pubmed, Web of Science, Embase, Cochrane Library and CNKI literature databases were searched in order to identify randomized controlled clinical trials where the association between the anti-inflammatory effect of statin and RA was investigated. Two researchers performed data extraction from eligible independently. Quality parameters and risk of bias in the included studies were assessed according to Cochrane's guidelines. The pooled Standardized Mean Difference (SMD) with a 95%CI was used to assess the anti-inflammatory effect of statin in patients with RA.Fifteen randomized controlled clinical, classified as "high quality" and with a relatively low risk of selection bias, were included in the meta-analysis. Of these, eight reported that there was no difference in the level of serum total lipids between the atorvastatin-treated and the conventional treatment group. However, the pooled analysis showed that atorvastatin could increase the level of serum amount of high-density lipoprotein (HDL) in RA patients by approximately x ± SD95% [HDL: SMD = 0.807, 95%CI = (0.187, 1.426), p = .011]. Meanwhile atorvastatin could reduce the level of serum low-density lipoprotein (LDL), total cholesterol (TC), and triglyceride (TG) in RA patient by x ± SD95% [LDL: SMD = -4.015, 95%CI = (-5.848, -2.183), p = .000; TC: SMD = -4.497, 95%CI = (-6.457, -2.537), p = .000; TG: SMD = -1.475, 95%CI = (-2.352, -0.599), p = .001]. Nine studies reported a change in C-Reactive Protein (CRP) after atorvastatin treatment, and the pooled analysis showed that atorvastatin decreased CRP in RA patients by x ± SD95% [SMD = -3.033, 95%CI = (-4.460, -1.606), p = .000]. Seven studies investigated the change of Erythrocyte Sedimentation Rate (ESR), and the pooled analysis showed that atorvastatin decreased ESR by x ± SD95% [SMD = -2.097, 95%CI = (-3.408, -0.786), p = .002]. Nine studies reported the improvement of disease activity score in RA patients after taking atorvastatin for 12 weeks, and the pooled analysis showed atorvastatin could decrease the DAS28 score in RA patients by x ± SD95% [SMD = -2.001, 95%CI = (-3.191, -0.811), p = .001].Statins have a significant anti-inflammatory effect in RA patients. However, atorvastatin was superior to simvastatin both in terms of its anti-inflammatory and lipid-lowering activities.

Statin Use and Development of Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials and Observational Studies

Statins and Prevention of Atrial Fibrillation in Patients with Heart Failure.

The long-term usage of statin prevents adverse events in patients with atrial fibrillation

Usefulness of Statins Pretreatment for the Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population-Based Cohort Study

Prevention of atrial fibrillation after cardiac surgery by preoperative use of statins: a meta analysis

Statin Therapy is Associated with a Lower Risk of Heart Failure in Patients with Atrial Fibrillation: A Population‐Based Study

Update on the efficacy of statins in primary and secondary prevention of atrial fibrillation

Association between Statin use and the risk of atrial fibrillation in community-dwelling older people in Shanghai, China：a propensity score-matched study

Statin therapy in the prevention and treatment of atrial fibrillation

Perioperative Statin Administration with Decreased Risk of Postoperative Atrial Fibrillation, but Not Acute Kidney Injury or Myocardial Infarction: A Meta-Analysis

Effect of Statins Use on the Prevention of Venous Thromboembolism: a Meta-Analysis

Independent and Joint Association of Statin Therapy with Adverse Outcomes in Heart Failure Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy.

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

Effects of Statins on the Liver: Clinical Analysis of Patients with Ischemic Stroke

Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial

Early statin use is associated with improved outcomes in patients with atrial fibrillation and recent ischaemic stroke.

Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database

Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins

The Anti-Inflammatory Effects of Statins on Patients with Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of 15 Randomized Controlled Trials

The Association Between Statin Use and Risk of Age-Related Macular Degeneration